InsiderClue
← All stocks

CG Oncology, Inc.

CGON Net buying
CIK 0001991792 #1141 in the set updated 21 Sep 2026
Bought (120 mo)
$87.48M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$53.22M
$2.78M on a plan · $7.84M straight out of an exercise
Sold at will
$42.60M
3 of 43 sales
Net
+$34.26M
+$44.88M against sales at will

By person

8 insiders · 51 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Liu Brian Guan-Chyun
Director
$74.81M (2)
—
+$74.81M
1,886,236
2.13%
$137.66M
—
Song Hong Fang
Director
$5.00M (1)
$45.38M (7)
−$40.38M
3,517,859
3.97%
$256.73M
—
Decheng Capital Global Life Sciences Fund IV, L.P. entity
10% owner
$7.60M (1)
—
+$7.60M
4,958,812
5.59%
$361.89M
+432.9%
Mulay James
Director
—
$6.28M (16) scheduled
−$6.28M
0
0.0000%
$0.00
—
POST LEONARD E
Director
—
$1.56M (20) scheduled
−$1.56M
0
0.0000%
$0.00
—
Roche Corleen M.
CFO
$38.00K (1)
—
+$38.00K
2,000
0.0023%
$145.96K
—
Kasturi Vijay
Chief Medical Officer
$24.99K (1)
—
+$24.99K
1,315
0.0015%
$95.97K
—
Kuan Arthur
Chief Executive Officer
—
—
—
198,916
0.2244%
$14.52M
+450.2%

Individual transactions

3
Insider
Date
Role
Action
Shares
Price
Amount
Song Hong Fang
16 Dec 2024
Director
Sell indirect
700,000
$28.00
$19.60M
Song Hong Fang
29 Aug 2024
Director
Sell indirect
226,245
$35.36
$8.00M
Song Hong Fang
29 Aug 2024
Director
Sell indirect
424,210
$35.36
$15.00M
Show all 51 transactions →

What was left out

Form 4 filings counted 74
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 36
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 9,247,735
History held since 26 Jan 2024